AN2 THERAPEUTICS, INC.

Insiders AN2 Therapeutics, Inc.

Equities

ANTX

US0373261058

Real-time Estimate Cboe BZX Other stock markets 11:56:09 2024-05-20 am EDT			5-day change	1st Jan Change
2.2 ^USD	-3.08%		-5.96%	-89.21%

May. 16	Evercore ISI Adjusts Price Target on AN2 Therapeutics to $2 From $7, Maintains In-Line Rating	MT
Apr. 03	North American Morning Briefing : Powell Awaited -2-	DJ

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

An2 Therapeutics Insider Sold Shares Worth $1,911,410, According to a Recent SEC Filing	Jan. 22	MT
An2 Therapeutics Insider Sold Shares Worth $1,704,513, According to a Recent SEC Filing	23-10-04	MT
An2 Therapeutics Insider Sold Shares Worth $150,708, According to a Recent SEC Filing	23-09-29	MT
Insider Sell: An2 Therapeutics	23-09-08	MT
AN2 Therapeutics, Inc. Announces Executive Changes	23-09-08	CI
AN2 Therapeutics, Inc. Appoints Maggie Fitzpatrick to its Board of Directors	22-05-09	CI
Insider Buy: AN2 Therapeutics	22-04-01	MT
Insider Buy: AN2 Therapeutics	22-04-01	MT
AN2 Therapeutics, Inc. Appoints Patricia Martin and Stephanie Wong to the Board of Directors	22-01-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW